Wednesday, December 2, 2009

Hana Biosciences Completes Enrollment in Pivotal Phase 2 rALLy Clinical Trial of Marqibo(R) in Acute Lymphoblas.. http://bit.ly/7uY65a
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)